Steve Mitchell

Dr. Stephen Mitchell is a PhD pharmacologist with over 30 years of research experience in academia (Institute of Psychiatry, London) and industry (Sandoz and Eli Lilly). His expertise lies in neurochemistry, where he applies a systems and multi-analyte approach to understanding brain pathways in CNS disorders.

He has contributed to numerous projects focused on identifying new therapeutic targets for psychiatric and neurodegenerative diseases, including Parkinson’s and Alzheimer’s, as well as chronic pain management.